Cargando…
Evolving Therapeutic Approaches for Older Patients with Acute Myeloid Leukemia in 2021
SIMPLE SUMMARY: The better understanding of disease biology, the availability of new effective drugs and the increased awareness of patients’ heterogeneity in terms of fitness and personal expectations has made the current treatment paradigm of AML in the elderly very challenging. Here, we discuss t...
Autores principales: | Urbino, Irene, Secreto, Carolina, Olivi, Matteo, Apolito, Vincenzo, D’Ardia, Stefano, Frairia, Chiara, Giai, Valentina, Aydin, Semra, Freilone, Roberto, Dellacasa, Chiara, Giaccone, Luisa, Ferrero, Dario, Audisio, Ernesta, Busca, Alessandro, Cerrano, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534216/ https://www.ncbi.nlm.nih.gov/pubmed/34680226 http://dx.doi.org/10.3390/cancers13205075 |
Ejemplares similares
-
Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors
por: Boscaro, Eleonora, et al.
Publicado: (2023) -
Levofloxacin Prophylaxis Versus no Prophylaxis in Acute Myeloid Leukemia During Post-Induction Aplasia: a Single Center Study
por: Urbino, Irene, et al.
Publicado: (2023) -
Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis
por: Aydin, Semra, et al.
Publicado: (2023) -
PB2057: THE COMBINATION OF ANTI-COMPLEMENT THERAPY AND CYCLOSPORINE +/- ELTROMBOPAG IN PNH IS EFFECTIVE AND SAFE: A REAL-LIFE OBSERVATIONAL STUDY.
por: Catania, Federica, et al.
Publicado: (2023) -
P678: EARLY WARNING RESPONSES IN CML PATIENTS: A REAL-LIFE TURIN EXPERIENCE
por: Giai, Valentina, et al.
Publicado: (2023)